Eli Lilly’s Zepbound, a weight loss drug, showed promise in treating sleep apnea in obese adults, the company announced Wednesday. Results from late-stage...
By 193cc Agency CouncilApril 18, 2024New Genetic Variants Discovered, Potentially Increasing Obesity Risk Six-Fold A groundbreaking study published in Nature Genetics has unveiled two genetic variants that could...
By 193cc Agency CouncilApril 4, 2024